文献速递妇科

脂联素经AMPK/mTOR/S6K1通路对子宫内膜癌细胞的作用及其胰岛素增敏效应

[Effect of AMPK/mTOR/S6K1 pathways and the insulin-sensitizing effect for adiponectin in endometrial cancer cells].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2018-01-01

该研究在子宫内膜癌HEC-1B细胞中观察脂联素对AMPK/mTOR/S6K1信号通路及胰岛素增敏效应的影响,发现脂联素可抑制mTOR、S6K1活化并诱导IRS1酪氨酸磷酸化,Ad组增殖抑制率高于Ad+抑制剂组,Ad组穿膜细胞数少于Ad+抑制剂组。

要点

  • HEC-1B细胞中AdipoR1 mRNA及蛋白表达高于AdipoR2(P<0.05)。
  • 脂联素20 μg/ml作用30 min时AMPK活化达峰值,并抑制mTOR、S6K1活化(P<0.05)。
  • Ad组增殖抑制率(0.68±0.34)%高于Ad+抑制剂组(0.24±0.04)%(t=17.88,P<0.05)。

核心结论

  • 脂联素可能通过AMPK/mTOR/S6K1信号通路抑制子宫内膜癌HEC-1B细胞增殖和迁移。
  • 脂联素可能通过调控AMPK/S6K1/IRS1通路增加HEC-1B细胞对胰岛素的敏感性。

研究设计与样本

  • 实验分为4组:Ad组(20 μg/ml脂联素作用30 min)、抑制剂组(10 μmol/L复合物C作用30 min)、Ad+抑制剂组(10 μmol/L复合物C预处理30 min后加20 μg/ml脂联素作用30 min)、对照组(仅加无血清DMEM培养基)。
  • 用荧光定量PCR及蛋白印迹法检测AdipoR1、AdipoR2 mRNA和蛋白表达。
  • 以不同浓度脂联素(2.5、5、10、20 μg/ml)作用30 min,增敏实验再加50 nmol/L胰岛素作用5 min;以20 μg/ml脂联素作用不同时间(15、30、45、60 min),增敏实验再加50 nmol/L胰岛素作用5 min,蛋白印迹法检测AMPK、mTOR、S6K1活化及IRS1酪氨酸磷酸化。
  • 用CCK-8法检测4组HEC-1B细胞增殖能力,体外穿膜实验检测4组细胞迁移能力。

主要发现

  • HEC-1B细胞中AdipoR1 mRNA及蛋白表达分别为8.50±0.09、0.91±0.03,高于AdipoR2 mRNA及蛋白的1.00±0.00、0.69±0.03(P<0.05)。
  • 脂联素以时间、浓度依赖方式诱导HEC-1B细胞AMPK蛋白活化水平增高,但抑制mTOR、S6K1蛋白活化水平(P<0.05)。
  • 脂联素浓度为20 μg/ml、作用时间为30 min时,AMPK蛋白活化水平达到峰值。
  • 脂联素以浓度依赖方式诱导IRS1酪氨酸磷酸化水平增高(P<0.05)。
  • Ad组HEC-1B细胞增殖抑制率为(0.68±0.34)%,Ad+抑制剂组为(0.24±0.04)%,两组比较差异有统计学意义(t=17.88,P<0.05);Ad组穿膜细胞数为(77±8)个,Ad+抑制剂组为(132±13)个,两组比较差异有统计学意义(t=-7.34,P<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore effect of AMP-activated protein kinase (AMPK) /mammalian target of rapamycin (mTOR) /ribosomal protein S6 kinase-1 (S6K1) signaling pathways and the insulin-sensitizing effect by adiponectin in endometrial cancer HEC-1B cells. Methods: The experiments were divided into 4 groups, adiponectin (Ad) group (HEC-1B cells treated with 20 μg/ml adiponectin for 30 minutes) , inhibitor group (HEC-1B cells treated with 10 μmol/L compound C for 30 minutes) , inhibitor+ Ad group (HEC-1B cells treated with 10 μmol/L compound C for 30 minutes following incubation with 20 μg/ml adiponectin for 30 minutes) , control group (only added the culture medium without serum DMEM) . (1) Real-time quantitative PCR and western blot analysis were used to detect the level of mRNA and protein of adiponectin receptor (AdipoR) 1 and AdipoR2. (2) Western blot analysis were used to detect phosphorylation of AMPK, mTOR, S6K1 or insulin receptor substrate 1 (IRS1) protein expression with stimulation in different concentrations of adiponectin (2.5, 5, 10, and 20 μg/ml) , or following incubation with insulin 50 nmol/L for 5 minutes; or treated with 20 μg/ml adiponectin for different times (15, 30, 45, and 60 minutes) , or following incubation with insulin 50 nmol/L for 5 minutes. (3) Cell counting kit-8 (CCK-8) assay was performed to investigate the cell proliferation, and transwell chamber assay was used to detect the cell migration in different groups. Results: (1) The relative expression level of AdipoR1 mRNA and protein were higher than AdipoR2 in HEC-1B cell (8.50±0.09 to 1.00±0.00, and 0.91±0.03 to 0.69±0.03; P<0.05) . (2) The phosphorylation level of p-AMPK was significantly induced, and the phosphorylation level of p-mTOR and p-S6K1 proteins, and 20 μg/ml adiponectin at 30 minutes, AMPK protein had the highest level of activation. (3) Adiponectin induces increased tyrosine phosphorylation of IRS1 in a time-and concentration-dependent manner. (4) The proliferation inhibition ratio in Ad group (0.68±0.34) % was much more than that in inhibitor+Ad group (0.24±0.04) % (t=17.88, P<0.05) . The number of cell migration in Ad group (77±8) was much more than that in inhibitor+Ad group (132±13; t=-7.34, P<0.05) . Conclusions: Adiponectin maybe inhibit proliferation and migration of endometrial cancer cells through AMPK/mTOR/S6K1 signal pathway. Adiponectin insensitizes insulin signaling may by regulating by the AMPK/S6K1/IRS1 pathway. 目的: 探讨脂联素对子宫内膜癌HEC-1B细胞腺苷酸活化蛋白激酶(AMPK)/哺乳类雷帕霉素靶蛋白(mTOR)/核糖体蛋白S6激酶1(S6K1)信号通路及胰岛素增敏效应的影响。 方法: 实验分为4组:脂联素组(Ad组,加入20 μg/ml的脂联素作用30 min);抑制剂组(加入10 μmol/L的AMPK抑制剂——复合物C作用30 min);脂联素+抑制剂组(Ad+抑制剂组,10 μmol/L复合物C预处理30 min后,再加入20 μg/ml脂联素作用30 min);对照组(仅加入无血清DMEM培养基)。(1)荧光定量PCR技术及蛋白印迹法检测HEC-1B细胞中脂联素受体(AdipoR)1、AdipoR2 mRNA和蛋白的表达水平。(2)以不同浓度(分别为2.5、5、10、20 μg/ml)脂联素作用于HEC-1B细胞30 min,增敏实验时再加50 nmol/L胰岛素作用5 min;以20 μg/ml脂联素作用于HEC-1B细胞不同时间(分别为15、30、45、60 min),增敏实验时再加50 nmol/L胰岛素作用5 min。蛋白印迹法检测HEC-1B细胞中AMPK、mTOR、S6K1蛋白活化水平以及胰岛素受体底物1(IRS1)酪氨酸磷酸化水平。(3)活细胞计数(CCK-8)法检测4组HEC-1B细胞的增殖能力,体外穿膜实验检测4组HEC-1B细胞的迁移能力。 结果: (1)在HEC-1B细胞中,AdipoR1 mRNA及蛋白的表达水平分别为8.50±0.09、0.91±0.03,明显高于AdipoR2 mRNA及蛋白(分别为1.00±0.00、0.69±0.03;P<0.05)。(2)脂联素以时间、浓度依赖方式诱导HEC-1B细胞中AMPK蛋白活化水平增高但抑制mTOR、S6K1蛋白活化水平(P<0.05),且脂联素浓度为20 μg/ml、作用时间为30 min时,AMPK蛋白的活化水平均达到峰值。脂联素以浓度依赖方式诱导IRS1酪氨酸磷酸化水平增高(P<0.05)。(3)Ad组HEC-1B细胞增殖的抑制率为(0.68±0.34)%,Ad+抑制剂组为(0.24±0.04)%,两组比较,差异有统计学意义(t=17.88,P<0.05)。Ad组穿膜细胞数为(77±8)个,Ad+抑制剂组为(132±13)个,两组比较,差异有统计学意义(t=-7.34,P<0.05)。 结论: 脂联素通过AMPK/mTOR/S6K1信号通路发挥抑制子宫内膜癌HEC-1B细胞增殖的效应,并通过调控AMPK/S6K1/IRS1信号通路增加HEC-1B细胞对胰岛素的敏感性。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Cai ZF, Deng L, Wang MM, et al. [Effect of AMPK/mTOR/S6K1 pathways and the insulin-sensitizing effect for adiponectin in endometrial cancer cells]. Zhonghua Fu Chan Ke Za Zhi. 2018. PMID: 30138966. doi:10.3760/cma.j.issn.0529-567x.2018.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。